Metformin improves PCOS clinical but not metabolic or endocrine outcomes

09 Feb 2017


Metformin improved clinical outcomes, including reduced BMI, waist-to-hip ratio and blood pressure, in women with PCOS, but did not affect metabolic or endocrine outcomes, according to findings published in Current Medical Research and Opinion.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story